# DiaMedica Therapeutics Inc.: Form 8-K/A, filed Mar 10, 2023

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K/A
- Filed: 2023-03-10
- Accepted by EDGAR: Mar 10, 2023, 08:00 ET
- Period: 2023-03-01
- Accession: 0001437749-23-006083
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/dmtp20230309_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/dmtp20230309_8ka.htm

Filed Mar 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-006083. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.